Insight into Burkitt's Lymphoma from Immunoglobulin Variable Region Gene Analysis

References

• Wright D.H. What is Burkitt's Lymphoma?. J. Pathology 1997; 182: 125–127
   PubMed Web of Science ®Google Scholar
• Burkitt D.P. Sarcoma involving jaws in African children. Br. J. Surg. 1958; 46: 218–223
   PubMed Web of Science ®Google Scholar
• Wright D.H. Involvement of the jaw in Burkitt's tumor. Lancet 1963; 2: 151
   PubMedGoogle Scholar
• Burkitt D.P. Burkitt's lymphoma outside the known endemic areas of Africa and New Guinea. Int. J. Cancer 1967; 2: 562–565
   PubMed Web of Science ®Google Scholar
• Berard C., O'Conor G.T., Thomas L.B., Torloni H. Histopathological definition of Burkitt's tumor. Bull. WHO. 1969; 40: 601–607
   PubMed Web of Science ®Google Scholar
• Wright D., Maclver P., Carter R. Childhood non-Hodgkin's lymphomas in the United Kingdom: findings from the UK children's cancer study group. J. Clin. Path. 1997; 50: 128–134
   PubMed Web of Science ®Google Scholar
• Magrath I. The Pathogenesis of Burkitt's Lymphoma. Adv. Cancer. Res 1990; 55: 133–270
   PubMedGoogle Scholar
• Lenoir G., Philip T., Sohier R. Burkitt type lymphoma: EBV association and cytogenetic markers in cases from various geographical locations. Pathogenesis of Leukaemias and Lymphomas: Environmental Influences, I.T. Magrath, G.T. O'Conor, B. Ramat. Raven Press, New York 1984; 285–296
   Google Scholar
• Rowc M., Rooney C.M., Edwards C.F., Lenoir G.M., Rickinson A.B. Epstein-Barr virus status and tumor cell phenotype in sporadic Burkitt's lymphoma. Int. J. Cancer 1986; 37: 367–373
   PubMed Web of Science ®Google Scholar
• Burkitt D.P. General features and facial tumors. Burkitt's Lymphoma, D.P. Burkitt, D.H. Wright. E and S Livingstone, Edinburgh and London 1970; 6–L5
   Google Scholar
• Wright D.H. Gross distribution and morphology. Burkitt's Lymphoma, D.P. Burkitt, D.H. Wrights. E and S Livingstone, Edinburgh and London 1970; 64–81
   Google Scholar
• Dalla-Favera R., Bregni M., Erikson J., Patterson D., Gallo R.W., Croce C.M. Human c-myc one gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc. Natl. Acad. Sci. USA 1982; 79: 7824–7827
   PubMed Web of Science ®Google Scholar
• Taub R., Kirsch L., Morton C., Lenoir G., Swan D., Tronick S., Aaronson S., Leder P. Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells. Proc. Natl. Acad. Sci. USA 1982; 79: 7837–7841
   PubMed Web of Science ®Google Scholar
• Cesarman E., Dalla-Favcra R., Bentley D., Groudine M. Mutations in the first exon are associated with altered transcription of c-myc in Burkitt's lymphoma. Science 1987; 238: 1272–1275
   PubMed Web of Science ®Google Scholar
• Rabbitts T.H., Hamlyn P.H., Baer R. Altered nucleotide sequences of a traslocated c-myc gene in Burkitt's lymphoma. Nature 1983; 306: 760–765
   PubMed Web of Science ®Google Scholar
• Bhatia K., Huppi K., Sangler G., Siwarski D., Iyer R., Magrath I. Point mutations in the c-myc transactivation domain are common in Burkitt's lymphoma and mouse plasmacytomas. Nature Genetics 1993; 5: 56–61
   PubMed Web of Science ®Google Scholar
• Guy K., Middleton P.G., Bonsai N.S., Ross J.A., Stell C.M. Recurrent mutation of immunoglobulin and c-myc genes and differentiated expression of cell surface anti gens occur in varient cell lines derived from a Burkitt's lymphoma. Int. J. Cancer 1990; 45: 109–118
   PubMed Web of Science ®Google Scholar
• Zeiglcr J.L., Beckstead J.A., Volberding P.A., Abrams D.L., Levine A.M., Likes R.J., Gill P.S., Burkes R.L., Meyer P.R., Metroka C.E., Mouradian J., Moore A., Riggs S.A., Butler J.J., Cabanillas F.C., Hersh E., Newell G.R., Laubenstcin L.J., Knowles D., Odajnyk C., Raphael B., Koziner B., Urmacher C., Clarkson B.D. Non-Hodgkin's lymphoma in 90 homosexual men. Relation to generalized lymphadenopathy and the acquired immunodeficiency syndrome. N. Engl. J. Med 1984; 311: 565–570
   PubMed Web of Science ®Google Scholar
• Pillici P., Knowles D., Magrath I., Dalla-Favera R. Chromosomal breakpoints and the structural alterations of the c myc locus differ in endemic and sporadic forms of Burkitt lymphoma. Proc. Natl. Acad. Sci. USA 1986; 83: 2984–2990
   PubMed Web of Science ®Google Scholar
• Subar M., Neri A., Inghirami G., Knowles D.M., Dalla-Favera R. Frequent c-myc oncogene activation and infrequent presence of Epstein-Barr virus genome in AIDS-associated lymphoma. Blood 1988; 72: 667–671
   PubMed Web of Science ®Google Scholar
• Hamilton-Dutoit S.J., Raphael M., Audouin J., Diebold J., Lisse I., Pedcrsen C., Oksenhendler E., Marelle I., Pallensen G. In situ demonstration of Epstein-Barr virus small RNAs (EBER-1) in acquired immunodeficiency syndrome-related lymphomas: correlation with tumor morphology and primary site. Blood 1993; 92: 610–624
   Google Scholar
• Mann R.B., Jaffe E.S., Braylan R.C., Nanba K., Frank M.M., Zeigler J.L., Berard C.W. Non-endemic Burkitt's lymphoma: a B-cell tumor related to germinal centers. N. Engl. J. Med 1976; 295: 685–691
   PubMed Web of Science ®Google Scholar
• Wright D.H. Histogenesis of Burkitt's lymphoma. Burkitt's Lymphoma: A Human Cancer Model, G. Lenoir, G. O'Conor, C.L.M. Olwcny. IARC Scientific Publications, Lyon 1985; 37–45
   Google Scholar
• Bahler D.W., Cambell M.J., Hart S., Miller R.A., Levy S., Levy R. Ig VH gene expression among human follicular lymphomas. Blood 1991; 78: 1561–1568
   PubMed Web of Science ®Google Scholar
• Stevenson F.K., Spellerberg M.B., Treasure J., Chapman C.J., Silberstein L.E., Hamblin T.J., Jones D.B. Differential usage of an Ig heavy chain variable region gene by human B-cell tumors. Blood 1993; 82: 224–230
   PubMed Web of Science ®Google Scholar
• Hsu F.J., Levy R. Preferential use of the VH4 Immunoglobulin gene family by diffuse large cell lymphoma. Blood 1997; 86: 3072–3082
   Web of Science ®Google Scholar
• Johnson T.A., Razzenti L.Z., Kipps T.J. Ig VH1 genes expressed in B-cell chronic lymphocytic leukemia exhibit distinctive molecular features. J. Immunol. 1997; 158: 235–246
   PubMed Web of Science ®Google Scholar
• Oscier D.G., Thompsett A., Zhu D., Stevenson F.K. Differential rates of somatic hypermutation in VH genes among subsets of chronic lymphocytic leukemia defined by chromosomal abnormalities. Blood 1997; 89: 4153–4160
   PubMed Web of Science ®Google Scholar
• Stevenson F.K., Spellerberg M.B., Chapman C.J., Hamblin T.J. Differential usage of an autoantibody-associated VH gene, VH4-21, by human B-cell tumors. Leuk. Lymphoma 1995; 16: 379–384
   PubMed Web of Science ®Google Scholar
• Pritsch O., Magnac C., Dumas G., Egile C., Dighiero G. V gene usage by seven hybrids derived from CD5+ B-cell chronic lymphocytic leukemia and displaying autoantibody activity. Blood 1993; 82: 3103–3112
   PubMed Web of Science ®Google Scholar
• Bessudo A., Cherepakhin V., Johnson T.A., Razzenti L.Z., Feigal E., Kipps T.J. Favored use of immunoglobulin VH4 genes in AIDS-associated B-cell lymphoma. Blood 1996; 88: 252–260
   PubMed Web of Science ®Google Scholar
• Berek C., Milstein C. Mutation drift and repertoire shift in the maturation of the immune response. Immunol. Rev. 1987; 96: 23–41
   PubMed Web of Science ®Google Scholar
• Kocks C., Rajewsky K. Stable expression and somatic hypermutation of antibody V regions in B-cell development pathways. Ann. Rev. Immunol. 1989; 7: 537–559
   PubMed Web of Science ®Google Scholar
• Hummel M., Tamaru J., Kalvelage B., Stein H. Mantle Cell (Previously centrocytic) lymphomas express VH genes with no or very little somatic mutations like the physiologic cells of the follicle mantle. Blood 1994; 84: 403–407
   PubMed Web of Science ®Google Scholar
• Kuppers R., Rajewsky K., Hansmann M.-L. Diffuse large cell lymphomas are derived from mature B-cells carrying V region genes with a high load of somatic mutations and evidence of selection for antibody expression. Eur. J. Immunol. 1997; 21: 1398–1405
   Web of Science ®Google Scholar
• Sahota S., Hamblin T., Oscier D.G., Stevenson F.K. Assessment of the role of clonogenic B-lymphocytes in the pathogenesis of multiple myeloma. Leukemia 1994; 8: 1285–1289
   PubMed Web of Science ®Google Scholar
• Qin Y., Greiner A., Trunk M.J.K., Schmausser B., Ott M.M., Muller-Herelink H.K. Somatic hypermutation in low-grade mucose-associated lymphoid tissue-type B-cell lymphoma. Blood 1995; 86: 3528–3534
   PubMed Web of Science ®Google Scholar
• Zelenetz A.D., Chen T.T., Levy R. Clonal expansion in follicular lymphoma occurs subsequent to antigenic selection. J. Exp. Med 1992; 176: 1137–1148
   PubMed Web of Science ®Google Scholar
• Bahler D.W., Levy R. Clonal evolution of a follicular lymphoma: Evidence for antigen selection. Proc. Natl. Acad. Sci. USA 1992; 89: 6770–6774
   PubMed Web of Science ®Google Scholar
• Zhu D., Hawkins R.E., Hamblin T.J., Stevenson F.K. Clonal history of a human follicular lymphoma as revealed in the immunoglobulin variable region genes. Br. J.Haem. 1994; 86: 505–512
   PubMed Web of Science ®Google Scholar
• Bahler D.W., Miklos J.A., Swerdlow S.H. Ongoing Ig hypermutation in salivary gland mucosa-associaled lymphoid tissue-type lymphomas. Blood 1997; 89: 3335–3344
   PubMed Web of Science ®Google Scholar
• Moazzeni M., Mosayyebi G., Stevenson F.K., Abbot S., Mageed R.A., Shokri F. Biased utilization of immunoglobulin variable region heavy and light chain genes by the malignant CD5-negative B lymphocytes from patients with Burkitt's lymphoma. Int. J. Cancer 1994; 58: 226–232
   PubMed Web of Science ®Google Scholar
• Chapman C.J., Mockridge C.I., Rowe M., Rickinson A., Stevenson F.K. Analysis of VH genes used by neoplastic B-cells in endemic Burkitt's lymphoma show somatic hypermutation and intraclonal heterogeneity. Blood 1995; 85: 2176–2181
   PubMed Web of Science ®Google Scholar
• Chapman C.J., Zhou J.X., Gregory C., Rickinson A., Stevenson F.K. VH and VL gene analysis in sporadic Burkitt's lymphoma shows somatic hypermutation, intraclonal heterogeneity, and a role for antigen selection. Blood 1996; 88: 3562–3568
   PubMed Web of Science ®Google Scholar
• Klein U., Klein G., Ehlin-Henriksson B., Rajewsky K., Kuppers R. Burkitt's Lymphoma is a malignancy of mature B-cells expressing somatically mutated V region genes. Mol. Med 1995; 1: 495–505
   PubMed Web of Science ®Google Scholar
• Cowley C.G., Carroll W.L., Johnston J.M. The absence of ongoing immunoglobulin gene hypermutation suggests a distinct mechanism for c-myc mutation in endemic Burkitt's lymphoma. J. Ped. Hamatol./Oncol 1996; 18: 29–35
   PubMed Web of Science ®Google Scholar
• Tamaru J., Hummel M., Marafioti T., Kavelage B., Leoncini L., Minacci C., Tosi P., Wright D., Stein H. Burkitt's lymphomas express VH genes with a moderate number of antigen-selected somatic mutations. Am. J. Pathol 1995; 147: 1398–1407
   PubMed Web of Science ®Google Scholar
• Riboldi P., Gaidano G., Schettino E.W., Steger T.G., Knowles D.M., Dalla-Favera R., Casali P. Two Acquired Immunodeficiency Syndrome-associated Burkitt's Lymphomas produce specific anti-i IgM cold agglutinins using somatically mutated VH4-21 segments. Blood 1994; 83: 2952–2960
   PubMed Web of Science ®Google Scholar
• Ng V.L., Hurt M.H., Fein C.L., Khayam-Bashi F., Marsh J., Nunes W.M., McPhaul L.W., Feigal E., Nelson P., Herndier B.G., Shiramizu B., Reyes G.R., Fry K.E., McGrath M.S. IgMs produced by two Acquired Immune Deficiency Syndrome lymphoma cell lines: ig binding specificity and VH-gene putative somatic mutation analysis. Blood 1994; 83: 1067–1078
   PubMed Web of Science ®Google Scholar
• Jain R., Roncella S., Hashimoto S., Carbone A., Francia de Celle P., Foa R., Ferrarini M., Chiorazzi N. A potential role for antigen selection in the cional evolution of Burkitt's Lymphoma. J. Immunol 1994; 153: 45–52
   PubMed Web of Science ®Google Scholar
• Echlache V., Magnac C., Pritsch O., Dclecluse H.-J., Davi F., Raphael M., Dighiero G. Complete nucleotide sequence of Ig V genes in cases of Burkitt lymphoma associated with AIDS. Leuk. Lymphoma 1996; 20: 281–290
   PubMed Web of Science ®Google Scholar
• Daley M.D., Berinstein N.L., Siminovitch K.A. Immunoglobulin heavy chain variable gene utilization in human large cell and Burkitt's lymphoma cell lines. Clin. Invest. Med 1994; 17: 522–530
   PubMed Web of Science ®Google Scholar
• Carroll W.L., Yu M., Link M.P., Korsmeyer S.J. Absence of IgV region gene somatic hypermutation in advanced Burkitt's lymphoma. J. Immunol 1989; 143: 692–698
   PubMed Web of Science ®Google Scholar
• Berinischek H.-P., Foster S.J., Berinischek R.I., Dorner T., Domiati-Saad R., Lipsky P.E. Analysis of the Human VH gene repertoire: Differential effects of selection and somatic hypermutation on human peripheral CD5+/IgM+ and CD5-/IgM+ B cells. J. Clin. Invest. 1997; 99: 2488–2501
   PubMed Web of Science ®Google Scholar
• Cook G.P., Tomlinson I.H., Walter G., Riethman H., Carter N.P., Buluwela L., Rabbitts T.H., Winter G. A map of the human immunoglobulin VH locus completed by analysis of the telomeric region of chromosome 14q. Nat. Genet. 1994; 7: 162–168
   PubMed Web of Science ®Google Scholar
• Stevenson F.K., Smith G.J., North J., Hamblin T.J., Glennie M.J. Identification of normal B-cell counterparts of neoplastic cells which secrete cold agglutinins of anit-I and anti-I specificity. Br. J. Haematol. 1989; 72: 9–15
   PubMed Web of Science ®Google Scholar
• Kraj P., Friedman D.F., Stevenson F., Silbcrstein L.E. Evidence for the ovcrexprcssion of the V4-34 (VH4.21) Ig gene segment in the normal adult human peripheral blood B cell repertoire. J. Immunol. 1995; 154: 6406–6420
   PubMed Web of Science ®Google Scholar
• Shutte M.E.M., van Es J.H., Silberstein L.E., Logtenberg T. VH4-21-encoded natural autoantibodies with anti-i specificty mirror those associated with cold hemagglutinin disease. J. Immunol. 1993; 151: 6569–6576
   PubMed Web of Science ®Google Scholar
• Chang B., Casali P. The CDR1 sequence of a major proportion of human germline Ig VH genes are inherently susceptible to animo acid replacement. Immunol. Today. 1994; 15: 367–373
   PubMedGoogle Scholar
• Gutterez M., Bhatia K., Barriga F., Diez B., Muriel F.S., de Andreas M.L., Epelman S., Risveno C., Magrath I.T. Molecular epidemiology of Burkitt's lymphoma from South America: Differences in breakpoint location and Epstein-Barr virus association from tumours in other world regions. Blood 1992; 79: 3261–3266
   PubMed Web of Science ®Google Scholar
• Neri A., Barega F., Knowles D., Magrath I., Dalla-Favcra R. Different regions of the immunoglobulin heavy-chain locus are involved in chromosomal translocations in distinct pathogenic forms of Burkitt's lymphoma. Proc. Nat. Acad. Sci. USA. 1988; 85: 2748–2754
   PubMed Web of Science ®Google Scholar
• Chapman C.J., Spcllerberg M.B., Smith G.A., Carter N.P., Hamblin T.J., Stevenson F.K. Autoantired cell antibodies synthesized by patients with infectious mononucleosis utilize VH4-2I gene segment. J. Immunol. 1993; 151: 1051–1061
   PubMed Web of Science ®Google Scholar
• Berberian L., Valles-Ayoub Y., Sun N., Martinez-Maza O., Braun J. A VH clonal deficit in human immunodeficiency virus positive individuals reflects a B-cell maturation arrest. Blood 1991; 78: 175–179
   PubMed Web of Science ®Google Scholar
• David D., Demaison C., Bani L., Zouali M., Theze J. Selective variations in vivo of VH3 and VH1 gene family expression in peripheral B-cell IgM, IgD and IgG during HIV infection. Eur. J. Immunol. 1995; 25: 1524–1528
   PubMed Web of Science ®Google Scholar
• Rassenti L.Z., Kohsaka H., Kipps T.J. Analysis of immunoglobulin VH gene repertoire by an anchored PCR-ELISA. Ann. N.Y. Acad. Sci. 1995; 764: 463–473
   PubMed Web of Science ®Google Scholar
• Przybylski G.K., Goldman J., Ng V.L., McGrath M.S., Herndier B.G., Schenken D.P., Monroe J.G., Silberstein L.E. Evidence for early B-cell activation preceding the development of Epstein-Barr Virus-negative acquired immunodeficiency syndrome-related lymphoma. Blood 1996; 88: 4620–4629
   PubMed Web of Science ®Google Scholar
• Stamatopoulos K., Kosmas C., Papadaki T., Pouliou E., Belessi C., Afendaki S., Anagnostou D., Loukopoulos D. Follicular lymphoma immunoglobulin k light chains are affected by the antigen selection process, but to a lesser degree than their partner heavy chains. Br. J. Haematol. 1997; 96: 132–146
   PubMed Web of Science ®Google Scholar
• Denepoux S., Razánajaona D., Blanchard D., Meffre G., Capra J.D., Banchereau J., Lebecque S. Induction of somatic mutation in a human B cell line in vitro. Immunity. 1997; 6: 35–46
   PubMed Web of Science ®Google Scholar